Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 100
  • Start Date: April 12, 2021
Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops Fetalis by Massively Parallel Sequencing
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 80
  • Start Date: November 1, 2020
Effect of Usual Versus Reduced Lipid Intake on Unbound Bilirubin Levels, Brainstem Auditory Evoked Potentials, and Neurodevelopmental Outcome at 2 Years in Extremely Preterm Infants
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 84
  • Start Date: October 1, 2019
Safe Threshold to Discontinue Phototherapy in Term and Late Preterm Infant With Hemolytic Disease of Newborn: A Randomized Controlled Trial
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 55
  • Start Date: January 15, 2019
Whole Exome Sequencing and Whole Genome Sequencing for Non-immune Fetal/Neonatal Hydrops
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 500
  • Start Date: October 11, 2018
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 200
  • Start Date: July 1, 2018
Fetal Electrophysiologic Abnormalities in High-risk Pregnancies Associated With Fetal Demise
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 42
  • Start Date: October 31, 2017
Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: October 5, 2017
A Single-Center, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Alpha Thalassemia Major
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 1000
  • Start Date: June 8, 2017
FAST Trial Registry: Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
Showing 1-11 of 11